Cargando…
Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
Background: Thulium laser resection of bladder tumors (TmLRBT) is recently considered as a common treatment option for non-muscle-invasive bladder cancers (NMIBC), but whether it is superior to Transurethral resection of bladder tumors (TURBT) are still undetermined. Materials and Methods: We retros...
Autores principales: | Liu, Zheng, Long, Gongwei, Zhang, Yucong, Sun, Guoliang, Ouyang, Wei, Wang, Shen, Xu, Hao, Wang, Zhihua, Guan, Wei, Yu, Xiao, Hu, Zhiquan, Chen, Zhong, Wang, Shaogang, Li, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606824/ https://www.ncbi.nlm.nih.gov/pubmed/34820417 http://dx.doi.org/10.3389/fsurg.2021.759487 |
Ejemplares similares
-
Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intravesical BCG instillation
por: Sun, Jian-Xuan, et al.
Publicado: (2023) -
AB138. Experience on thulium laser treatment in transurethral resection of bladder tumor
por: Gan, Xiuguo, et al.
Publicado: (2016) -
Intravesical explosion during transurethral resection of bladder tumor: A case report
por: Xu, Chuan-Bing, et al.
Publicado: (2022) -
Extraperitoneal bladder perforation secondary to transurethral resection of bladder tumor
por: Luu, Doan Tien, et al.
Publicado: (2021) -
Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors
por: Sun, Kai, et al.
Publicado: (2021)